---
title: "MC: Record Q2 revenues, strong margins, and robust shareholder returns highlight ongoing growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294255579.md"
description: "Record Q2 and first half revenues were driven by higher average fees and expanded advisory capabilities, with Adjusted net income per share up 19% year-over-year in Q2. The firm maintained strong margins, returned $246.4 million to shareholders, and continues to invest in growth.Original document: Moelis & Company [MC] SEC 8-K Current Report — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-29T20:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294255579.md)
  - [en](https://longbridge.com/en/news/294255579.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294255579.md)
generator: "portal-rs"
---

# MC: Record Q2 revenues, strong margins, and robust shareholder returns highlight ongoing growth

Record Q2 and first half revenues were driven by higher average fees and expanded advisory capabilities, with Adjusted net income per share up 19% year-over-year in Q2. The firm maintained strong margins, returned $246.4 million to shareholders, and continues to invest in growth.

Original document: Moelis & Company \[MC\] SEC 8-K Current Report — Jul. 29 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MC.US](https://longbridge.com/en/quote/MC.US.md)

## Related News & Research

- [Buyout firm CVC explores $2 billion sale of Dr Teal's parent company, sources say](https://longbridge.com/en/news/298352786.md)
- [3 U.S. M&A Advisor Stocks Built For Higher Rates](https://longbridge.com/en/news/297754544.md)
- [Hikers 'relied too much' on AI and had to be rescued. A ranger says it wasn't the first AI-related mishap he's seen.](https://longbridge.com/en/news/298103029.md)
- [CHRW: AI-driven transformation and lean operations drive productivity, margin, and earnings growth](https://longbridge.com/en/news/298341851.md)
- [IDYA: Darovasertib and key pipeline assets advance toward major regulatory and clinical milestones](https://longbridge.com/en/news/298363053.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**